Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
SELLAS Life Sciences Group, Inc. See All Filings	D	2024-03-29 16:00:45 UTC
Amount To Be Raised $18,371,336 Associated Brokers / Dealers A.G.P./Alliance Global Partners CIK Number 0001390478 Filed Document 0001390478-24-000006 Exclusions or Exemptions 506b Accepted Date 2024-03-29 16:00:45 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Option To Acquire
SELLAS Life Sciences Group, Inc. See All Filings	D	2020-08-31 16:03:56 UTC
Amount To Be Raised $9,151,500 Associated Brokers / Dealers Maxim Group LLC CIK Number 0001390478 Filed Document 0001390478-20-000030 Exclusions or Exemptions 506b Accepted Date 2020-08-31 16:03:56 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Galena Biopharma, Inc. See All Filings	D	2016-07-26 13:16:17 UTC
Amount To Be Raised $9,100,000 Associated Brokers / Dealers Raymond James & Associates, Inc. CIK Number 0001390478 Filed Document 0000950166-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-07-26 13:16:17 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets $No Revenues Type of Security Option To Acquire
Galena Biopharma, Inc. See All Filings	D	2016-05-24 12:00:49 UTC
Amount To Be Raised $24,000,000 Associated Brokers / Dealers Armentum Partners, LLC CIK Number 0001390478 Filed Document 0001209191-16-122818 Exclusions or Exemptions 506b Accepted Date 2016-05-24 12:00:49 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
Galena Biopharma, Inc. See All Filings	D	2014-01-21 00:00:00 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001390478 Filed Document 0001181431-14-003271 Exclusions or Exemptions 506b Accepted Date 2014-01-21 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business OREGON Revenue or Assets Decline to Disclose Type of Security Equity